Clinical & Diagnostic
Reaction Biology Announces Integrated Drug Discovery Solution
The Reaction Oncology Platform is based on a network of strategic partners, including oncology and biophysics by the US and Germany-based Reaction Biology,...
February 03, 2022 | News
Pfizer and Alex Therapeutics to provide evidence-based Digital Therapeutics to patients,
"In our efforts to give patients access to new, innovative forms of therapy, it is our aim to fully benefit from the possibilities of digitization. Alex Th...
February 01, 2022 | News
Daewoong Pharmaceutical Released Positive Phase 3 Topline Results for New Antidiabetic Drug
Daewoong Pharmaceutical (Daewoong) has confirmed promising phase 3 topline results that focuses on the therapeutic effects as an Enavogliflozin monotherapy...
January 26, 2022 | News
Illumina collaborates with National Cancer Center Japan to address a leading cause of death in Asia
Illumina, Inc. (NASDAQ: ILMN) and the National Cancer Center Japan have announced an international joint research project that will use Illumina's hig...
January 25, 2022 | News
AHF Praises Merck for Generics – Urges Same from Vaccine Makers
“We praised Merck last October for its voluntary licensing agreement with MPP. Their efforts are now coming to fruition with an affordable ...
January 25, 2022 | News
Natera's Signatera™ MRD Test is Predictive of Chemotherapy Benefit in Colorectal Cancer
Analysis of 1,000+ patients, with 12 months mean follow up, demonstrates clinical utility of Signatera for informing post-surgical treatment decisions &nb...
January 24, 2022 | News
CliniSys acquires HORIZON Lab Systems
CliniSys is announcing the recent acquisition of HORIZON Lab Systems and the combination with Sunquest Information Systems, as CliniSys. This acquisi...
January 19, 2022 | News
LISCure Biosciences announces research collaboration with Mayo Clinic for rare liver diseases
LISCure has been conducting joint research with Mayo Clinic for NASH drugs since 2021, and this new collaboration is an agreement signed under the leadersh...
January 07, 2022 | News
Imvaq Therapeutics Signs a Service and Commercial Product License to Use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform
Under this agreement, ProBioGen develops a scalable process and granted Imvaq® a license to use ProBioGen's AGE1.CR.pIX cell line for the man...
January 07, 2022 | News
Virtue Diagnostics closes $100 million Series B Funding
Virtue Diagnostics is a global, platform-based IVD (In Vitro Diagnostic) company focusing on providing affordable clinical solutions at all disease stages ...
January 06, 2022 | News
Study highlights Antengene's complementary focus on diseases with a higher prevalence in China
Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and ...
January 03, 2022 | News
SyMap Medical Ltd. Announces its Strategic Collaboration with Pythagoras Medical
SyMap is focused on developing revolutionary device therapies for the unmet clinical needs of cardiovascular and pulmonary diseases, including hyperte...
December 30, 2021 | News
First Approval in Japan for the KEYTRUDA Plus LENVIMA Combination
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced that the Japanese Ministry of Health, Labour and Welfare (M...
December 29, 2021 | News
Regor Therapeutics announced authorization from the USFDA to proceed with Regor's Phase 1 clinical development plans for RGT-419B.
On December 23, Regor Therapeutics, a clinical-stage biotech company, announced authorization from the US Food and Drug Administration ...
December 28, 2021 | News
Most Read
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
